STAT1 and systemic lupus erythematosus: We observed that the increased levels of autoantibodies in the lupus mice were significantly reduced in dendritic cells that were pretreated with the STAT1 inhibitor or p38 MAPK inhibitor compared to those that were pretreated with the corresponding control (Fig. 4f, Table 3, Supplementary Fig. 12).